J 2020

Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures

TAN, Tiong Yang, Jiří SEDMÍK, Mark P. FITZGERALD, Rivka SUKENIK HALEVY, Liam KEEGAN et. al.

Základní údaje

Originální název

Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures

Autoři

TAN, Tiong Yang, Jiří SEDMÍK (203 Česká republika, domácí), Mark P. FITZGERALD, Rivka SUKENIK HALEVY, Liam KEEGAN (372 Irsko, domácí), Ingo HELBIG, Lina BASEL-SALMON, Lior COHEN, Rachel STRAUSSBERG, Wendy K. CHUNG, Mayada HELAL, Reza MAROOFIAN, Henry HOULDEN, Jane JUUSOLA, Simon SADEDIN, Lynn PAIS, Katherine B. HOWELL, Susan M. WHITE, John CHRISTODOULOU a Mary Anne O'CONNELL (372 Irsko, garant, domácí)

Vydání

The American Journal of Human Genetics, University of Chicago Press for the American Society of Human Genetics, 2020, 0002-9297

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10608 Biochemistry and molecular biology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 11.025

Kód RIV

RIV/00216224:14740/20:00114081

Organizační jednotka

Středoevropský technologický institut

UT WoS

000523306000005

Klíčová slova anglicky

ADAR2; microcephaly; migrating focal seizures; epilepsy; intellectual disability; RNA editing

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 9. 10. 2024 12:25, Mgr. Adéla Pešková

Anotace

V originále

The RNA editing enzyme ADAR2 is essential for the recoding of brain transcripts. Impaired ADAR2 editing leads to early-onset epilepsy and premature death in a mouse model. Here, we report bi-allelic variants in ADARB1, the gene encoding ADAR2, in four unrelated individuals with microcephaly, intellectual disability, and epilepsy. In one individual, a homozygous variant in one of the double-stranded RNA-binding domains (dsRBDs) was identified. In the others, variants were situated in or around the deaminase domain. To evaluate the effects of these variants on ADAR2 enzymatic activity, we performed in vitro assays with recombinant proteins in HEK293T cells and ex vivo assays with fibroblasts derived from one of the individuals. We demonstrate that these ADAR2 variants lead to reduced editing activity on a known ADAR2 substrate. We also demonstrate that one variant leads to changes in splicing of ADARB1 transcript isoforms. These findings reinforce the importance of RNA editing in brain development and introduce ADARB1 as a genetic etiology in individuals with intellectual disability, microcephaly, and epilepsy.

Návaznosti

GA19-16963S, projekt VaV
Název: Genetický model myši pro studium kontroly interferonu a zánětu
Investor: Grantová agentura ČR, A mouse genetic model to study the control of interferon and inflammation
90062, velká výzkumná infrastruktura
Název: Czech-BioImaging